Hunter Biden's Claims on Joe Biden's Debate Performance and Cancer Questioned

Hunter Biden recently suggested that his father, President Joe Biden's, poor performance in a June 2024 debate was due to fatigue from Ambien and linked it to the Stage 4 prostate cancer diagnosis he received in May 2025. Medical experts, however, dispute this connection.
According to medical professionals, the cancer, which was diagnosed months after the debate, is unlikely to have influenced his cognitive performance at the time. The cancer was identified during a routine physical examination, not due to symptoms affecting debate performance, according to oncologist Ravi Parikh. Experts emphasize that aggressive prostate cancer can develop rapidly and go undetected, particularly in older men where routine screening is not typically recommended.
FactCheck.org reports that there is no evidence suggesting that Biden or his medical team were aware of the cancer before its diagnosis. The cancer was classified as Stage 4 with bone metastases, a condition that was discovered after a nodule was found during a routine exam.
Hunter Biden's claims have been highlighted by various media outlets, but they remain speculative without supporting medical evidence. The timing of the cancer diagnosis aligns with standard medical practice and does not support retrospective claims about its influence on Biden's debate performance.